Dataset from A Randomised, Placebo-controlled, Double-blind, Single Dose, Cross-over Study to Evaluate the Efficacy and Safety of Orally Inhaled Tiotropium + Olodaterol as Both a Fixed Dose Combination and a Free Combination (Both Delivered by the Respimat® Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006614
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of this study is to evaluate the efficacy and safety of orally inhaled
tiotropium and olodaterol as both a fixed dose combination and a free combination with
respect to lung function and ECG parameters
创建时间：
2024-11-26
